Costs and benefits of a subtype-specific surveillance system for identifying Escherichia coli O157:H7 outbreaks - PubMed (original) (raw)

Costs and benefits of a subtype-specific surveillance system for identifying Escherichia coli O157:H7 outbreaks

E H Elbasha et al. Emerg Infect Dis. 2000 May-Jun.

Abstract

We assessed the societal costs and benefits of a subtype-specific surveillance system for identifying outbreak-associated Escherichia coli O157:H7 infections. Using data from Colorado, we estimated that if it averted five cases annually, the system would recover all its costs.

PubMed Disclaimer

Similar articles

• Escherichia coli O157:H7.
  Weir E. Weir E. CMAJ. 2000 Jul 25;163(2):205. CMAJ. 2000. PMID: 10934989 Free PMC article. No abstract available.
• An Escherichia coli O157:H7 outbreak?
  Bettelheim KA, Goldwater PN. Bettelheim KA, et al. Clin Infect Dis. 2000 Jun;30(6):984. doi: 10.1086/313831. Clin Infect Dis. 2000. PMID: 10880325 No abstract available.
• Enterohaemorrhagic Escherichia coli.
  Takeda Y. Takeda Y. World Health Stat Q. 1997;50(1-2):74-80. World Health Stat Q. 1997. PMID: 9282389 Review.
• Escherichia coli O157:H7 infection in nursing homes: review of literature and report of recent outbreak.
  Reiss G, Kunz P, Koin D, Keeffe EB. Reiss G, et al. J Am Geriatr Soc. 2006 Apr;54(4):680-4. doi: 10.1111/j.1532-5415.2006.00682.x. J Am Geriatr Soc. 2006. PMID: 16686882 Review.

Cited by

• The economic value of One Health in relation to the mitigation of zoonotic disease risks.
  Häsler B, Gilbert W, Jones BA, Pfeiffer DU, Rushton J, Otte MJ. Häsler B, et al. Curr Top Microbiol Immunol. 2013;365:127-51. doi: 10.1007/82_2012_239. Curr Top Microbiol Immunol. 2013. PMID: 24264885 Free PMC article. Review.
• Cost analysis of an integrated vaccine-preventable disease surveillance system in Costa Rica.
  Toscano CM, Vijayaraghavan M, Salazar-Bolaños HM, Bolaños-Acuña HM, Ruiz-González AI, Barrantes-Solis T, Fernández-Vargas I, Panero MS, de Oliveira LH, Hyde TB; iVPD Working Team. Toscano CM, et al. Vaccine. 2013 Jul 2;31 Suppl 3(0 3):C88-93. doi: 10.1016/j.vaccine.2013.05.036. Vaccine. 2013. PMID: 23777698 Free PMC article. Review.
• Modeling the cost-effectiveness of the integrated disease surveillance and response (IDSR) system: meningitis in Burkina Faso.
  Somda ZC, Perry HN, Messonnier NR, Djingarey MH, Ki SO, Meltzer MI. Somda ZC, et al. PLoS One. 2010 Sep 28;5(9):e13044. doi: 10.1371/journal.pone.0013044. PLoS One. 2010. PMID: 20927386 Free PMC article.
• Incidence and virulence determinants of verocytotoxin-producing Escherichia coli infections in the Brussels-Capital Region, Belgium, in 2008-2010.
  Buvens G, De Gheldre Y, Dediste A, de Moreau AI, Mascart G, Simon A, Allemeersch D, Scheutz F, Lauwers S, Piérard D. Buvens G, et al. J Clin Microbiol. 2012 Apr;50(4):1336-45. doi: 10.1128/JCM.05317-11. Epub 2012 Jan 11. J Clin Microbiol. 2012. PMID: 22238434 Free PMC article.
• Diversity, frequency, and persistence of Escherichia coli O157 strains from range cattle environments.
  Renter DG, Sargeant JM, Oberst RD, Samadpour M. Renter DG, et al. Appl Environ Microbiol. 2003 Jan;69(1):542-7. doi: 10.1128/AEM.69.1.542-547.2003. Appl Environ Microbiol. 2003. PMID: 12514039 Free PMC article.

References

1. 1. Am J Public Health. 1982 Jun;72(6):555-66 - PubMed
2. 1. Epidemiol Rev. 1991;13:60-98 - PubMed
3. 1. N Engl J Med. 1997 Aug 7;337(6):388-94 - PubMed
4. 1. MMWR Morb Mortal Wkly Rep. 1995 Jun 9;44(22):417-8 - PubMed
5. 1. JAMA. 1994 Nov 2;272(17):1349-53 - PubMed

Publication types

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • PubMed Central

• Medical

  • MedlinePlus Health Information